Gene · 85340
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies. | Mol Ther Nucleic Acids | 2023 | 37215154 | PubTator, text mining | PubMed |
| Microarray analysis of hub genes, non-coding RNAs and pathways in lung after whole body irradiation in a mouse model. | Int J Radiat Biol | 2023 | 37212632 | PubTator, text mining | PubMed |
| Identifying signatures of positive selection in human populations from North Africa. | Sci Rep | 2023 | 37210386 | PubTator, text mining | PubMed |
| Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics. | J Extracell Vesicles | 2023 | 37202906 | PubTator, text mining | PubMed |
| Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review. | Front Med (Lausanne) | 2023 | 37200963 | PubTator, text mining | PubMed |
| The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties. | Cell Mol Life Sci | 2023 | 37198527 | PubTator, text mining | PubMed |
| Application of Targeted Next-Generation Sequencing for the Investigation of Thalassemia in a Developing Country: A Single Center Experience. | Diagnostics (Basel) | 2023 | 37189480 | PubTator, text mining | PubMed |
| A novel compound heterozygous of β-thalassemia with HbG-Coushatta: case report of Iran. | Hum Genome Var | 2023 | 37188672 | PubTator, text mining | PubMed |
| Thalassemia and Nanotheragnostics: Advanced Approaches for Diagnosis and Treatment. | Biosensors (Basel) | 2023 | 37185525 | PubTator, text mining | PubMed |
| Prevalence of Thalassemia in the Vietnamese Population and Building a Clinical Decision Support System for Prenatal Screening for Thalassemia. | Mediterr J Hematol Infect Dis | 2023 | 37180206 | PubTator, text mining | PubMed |
| The Benefits and Challenges of Antibiotics-Non-Steroidal Anti-Inflammatory Drugs Non-Covalent Reaction. | Molecules | 2023 | 37175082 | PubTator, text mining | PubMed |
| A review of the effect of skin pigmentation on pulse oximeter accuracy. | Physiol Meas | 2023 | 37172609 | PubTator, text mining | PubMed |
| A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defects. | Hum Mol Genet | 2023 | 37171606 | PubTator, text mining | PubMed |
| Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer's Disease. | Sci Data | 2023 | 37160957 | PubTator, text mining | PubMed |
| Cord Blood Hematological Parameters of Fetuses Detected Different Thalassemia Genotypes in the Second Trimester of Pregnancy | Balkan Med J | 2023 | 37154826 | PubTator, text mining | PubMed |
| Influence of Voxelotor-hemoglobin complexes in the estimation of hemoglobin S levels by the current standard of care laboratory evaluation techniques. | Front Med (Lausanne) | 2023 | 37153104 | PubTator, text mining | PubMed |
| Reducing the time delay of oxygen transport to the neonate on continuous positive airway pressure support: A bench study. | Front Pediatr | 2023 | 37152305 | PubTator, text mining | PubMed |
| Fragment Linker Prediction Using the Deep Encoder-Decoder Network for PROTACs Drug Design. | J Chem Inf Model | 2023 | 37150933 | PubTator, text mining | PubMed |
| The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease. | Front Med (Lausanne) | 2023 | 37144034 | PubTator, text mining | PubMed |
| Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma. | Nat Commun | 2023 | 37142597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/85340/papers?page=20